Pharmaceuticals
Glenmark recalls anti-ulcer drug in the US over tablet mix-up
19 Apr 2014
Glenmark Pharmaceuticals Ltd is recalling 2,900 bottles of its anti-ulcer drug ranitidine from the US market after a tablet to treat high blood pressure was found in one of the bottles
After China, Iraq, Poland, GSK bribery probe now expands to Jordan, Lebanon
17 Apr 2014
The probe into a whistle-blower's allegations that British drug giant GlaxoSmithKline’s employees bribed doctors to prescribe its products has now expanded to the Middle East
After China and Iraq, GSK now faces bribery probe in Poland
14 Apr 2014
British drug giant GlaxoSmithKline (GSK), is under a criminal probe for allegedly bribing doctors in Poland for prescribing its asthma drug Seretide
Natco Pharma opposes Indian patent for Gilead’s hepatitis drug
11 Apr 2014
Gilead, whose medicine has been hailed by doctors as a breakthrough in treating hepatitis, has come under fire over its product's $1,000 per pill price tag in the US
Ranbaxy drug flows to Europe, US to dry up
09 Apr 2014
Sun Pharmaceutical Industries plans to phase out sales of Ranbaxy’s branded generic drugs in the US while continuing sales in other markets
Takeda fined record $6 bn over diabetes drug Actos; Eli Lilly $3 bn
08 Apr 2014
Takeda Pharmaceutical Co Ltd, Japan's largest drug firm, has been fined a record $6 billion in punitive damages by a US court over claims that it concealed cancer risks associated with its best-selling diabetes drug Actos
Irish drugmaker Mallinckrodt to buy Questcor Pharmaceuticals for $5.6 bn
08 Apr 2014
Questcor's main product, the injectable drug Acthar Gel, which it acquired in 2001 from Aventis, is used in the treatment of 19 conditions, including multiple sclerosis and infantile spasms
Sun Pharma, Ranbaxy to merge in Rs24,000 all-stock deal
07 Apr 2014
The merger will create India's largest pharmaceutical company and the world's fifth largest speciality generics company with annual emerging market sales nearing Rs6,000 crore
Health ministry seeks compulsory licence for Bristol-Myers' cancer drug
03 Apr 2014
A month’s dosage of Bristol-Myers Squibb’s patented drug Dasatinib, which is sold under the brand name `Sprycel’, costs around Rs60,000
J&J accepts $4 bn bid from Carlyle for its ortho-clinical diagnostics business
01 Apr 2014
Johnson & Johnson's ortho-clinical diagnostics unit was created in 1994 when it acquired the clinical diagnostics division of Eastman Kodak and formed Johnson & Johnson Clinical Diagnostics, which was then merged in 1997 with Ortho Diagnostic Systems
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
